A Study of LY3074828 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

March 6, 2018

Primary Completion Date

August 13, 2018

Study Completion Date

August 13, 2018

Conditions
Healthy
Interventions
BIOLOGICAL

LY3074828

Administered SC

Trial Locations (1)

75247-4989

Covance, Dallas

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT03456713 - A Study of LY3074828 in Healthy Participants | Biotech Hunter | Biotech Hunter